Marcum Wealth, LLC Vertex Pharmaceuticals Inc Transaction History

Marcum Wealth, LLC

$1.06 Billion
Q3 2024

A detailed history of Marcum Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Marcum Wealth, LLC holds 1,204 shares of VRTX stock, worth $542,245. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,204

Previous 1,178 2.21%

Holding current value

$542,245

Previous $552,000 1.27%

% of portfolio

0.05%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$460.0 - $505.78 $11,960 - $13,150	26 Added 2.21%	1,204 $559,000
Q2 2024 Jul 02, 2024	BUY	$392.81 - $485.53 $785 - $971	2 Added 0.17%	1,178 $552,000
Q1 2024 Apr 10, 2024	SELL	$407.69 - $446.08 $6,523 - $7,137	-16 Reduced 1.34%	1,176 $491,000
Q4 2023 Jan 10, 2024	SELL	$343.0 - $410.68 $24,696 - $29,568	-72 Reduced 5.7%	1,192 $485,000
Q3 2023 Oct 10, 2023	SELL	$338.18 - $362.46 $1,690 - $1,812	-5 Reduced 0.39%	1,264 $439,000
Q2 2023 Jul 13, 2023	SELL	$314.42 - $351.91 $40,245 - $45,044	-128 Reduced 9.16%	1,269 $446,000
Q1 2023 Apr 19, 2023	SELL	$283.23 - $323.1 $15,860 - $18,093	-56 Reduced 3.85%	1,397 $440,000
Q4 2022 Jan 12, 2023	BUY	$285.76 - $321.48 $2,857 - $3,214	10 Added 0.69%	1,453 $0
Q3 2022 Oct 11, 2022	SELL	$273.83 - $305.53 $20,537 - $22,914	-75 Reduced 4.94%	1,443 $418,000
Q2 2022 Jul 14, 2022	SELL	$234.96 - $292.55 $11,513 - $14,334	-49 Reduced 3.13%	1,518 $428,000
Q1 2022 Apr 20, 2022	SELL	$221.42 - $260.97 $18,599 - $21,921	-84 Reduced 5.09%	1,567 $409,000
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $17,701 - $22,345	-100 Reduced 5.71%	1,651 $363,000
Q3 2021 Nov 08, 2021	BUY	$181.39 - $202.99 $13,060 - $14,615	72 Added 4.29%	1,751 $318,000
Q2 2021 Aug 10, 2021	SELL	$187.49 - $221.1 $3,749 - $4,422	-20 Reduced 1.18%	1,679 $339,000
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $351,726 - $409,985	1,699 New	1,699 $365,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marcum Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marcum Wealth, LLC with notifications on news.

Account

Marcum Wealth, LLC Vertex Pharmaceuticals Inc Transaction History